You are viewing: Argentina Elastomeric Infusion Pumps Market analysis

The Argentina Elastomeric Infusion Pumps Market was valued at $7.2 Million in 2025 and projected to reach to $8.7 Million by 2030, representing a compound annual growth rate of 4.0%. Argentina's elastomeric infusion pumps market is poised for steady growth driven by healthcare infrastructure improvements and increasing adoption of portable drug delivery solutions.

Argentina Elastomeric Infusion Pumps Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Argentina Elastomeric Infusion Pumps Market Trends and Insights

  • Argentina's healthcare infrastructure and rising demand for portable drug delivery solutions are driving adoption of elastomeric infusion pump technology across hospitals and outpatient settings.
  • The market in Argentina reflects steady growth driven by increasing prevalence of chronic diseases and expanding access to advanced medical devices in the region. During the 2025–2030 forecast period, Argentina is expected to experience moderate but consistent market expansion as healthcare providers invest in cost-effective infusion delivery systems.
  • Argentina's regulatory environment and growing emphasis on patient-centric care are supporting the uptake of elastomeric pumps in oncology, pain management, and antibiotic therapy applications.
  • Market participants in Argentina are focusing on product innovation and strategic partnerships to strengthen their competitive position..

Key Market Statistics

  • CAGR (2025-2030) 4.0% CAGR
  • Market Size, 2025 ~USD 7.2 Million
  • Forecast, 2030 ~USD 8.7 Million
  • Country Argentina

Argentina Elastomeric Infusion Pumps Market Overview

Market Size & Growth :

Argentina's elastomeric infusion pumps market is valued at USD 7.2 million in 2025, with projected growth to USD 8.7 million by 2030, representing a steady 4.0% CAGR.

Healthcare Infrastructure Development :

Argentina's expanding healthcare system and modernization initiatives are creating increased demand for advanced drug delivery technologies in both public and private medical facilities.

Portable Drug Delivery Adoption :

Rising preference for portable and patient-friendly infusion solutions is driving elastomeric pump adoption across Argentine hospitals, clinics, and outpatient care centers.

Regional Market Position :

Argentina represents a significant market opportunity in Latin America, with growth rates aligned to regional healthcare expansion and increasing chronic disease management needs.

Argentina Elastomeric Infusion Pumps Market Dynamics

  • The country's focus on modernizing medical facilities and expanding access to advanced therapeutic technologies supports market expansion through 2030.
  • Growing prevalence of chronic diseases requiring long-term infusion therapy, combined with patient preference for mobility and independence, creates sustained demand for elastomeric pump systems across Argentine healthcare settings. The 4.0% CAGR reflects Argentina's developing market maturity and gradual healthcare sector investment.
  • Key growth drivers include rising awareness among healthcare providers, improving reimbursement policies, and expanding distribution networks.
  • Market players focusing on cost-effective solutions and local partnerships will find significant opportunities in Argentina's mid-sized but growing elastomeric infusion pump segment..

Related Ecosystem

Key Takeaways

  • Argentina's elastomeric infusion pumps market is valued at USD 7.2 million in 2025 and is forecast to reach USD 8.7 million by 2030.
  • Argentina is experiencing a 4.0% CAGR, reflecting steady demand for portable and cost-effective drug delivery solutions.
  • Chronic disease prevalence and healthcare modernization are key growth drivers for elastomeric infusion pump adoption in Argentina.
  • Argentina's market is characterized by increasing focus on outpatient care and home-based infusion therapy applications.

Elastomeric Infusion Pumps Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment HOME CARE SETTINGS (Setting)
Forecast Period 2025–2030
Growth Rate CAGR of 5.3% from 2025 to 2030
Largest Segment ACCESSORIES AND CONSUMABLES (Product)
Market Size Base Year (Billions) ~USD 1.15 (2025)
Revenue Forecast (Billions) ~USD 1.49 (2030)
Segments Covered Type, Application, End-Use Industry, Product, Setting

Argentina Elastomeric Infusion Pumps Market Report Segmentation

5 segment dimensions are covered across the global market.

By Type

  • Continuous Rate
  • Variable Rate

By Application

  • Analgesia/Pain Management
  • Antibiotics
  • Chemotherapy
  • Chemotherapy/Oncology
  • Diabetes Management
  • Gastroenterology
  • Hematology
  • Other Applications
  • Pain Management
  • Pediatrics/Neonatology

By End-Use Industry

  • Ambulatory Surgical Centers (Ascs)
  • Homecare Settings
  • Hospitals
  • Other End-Use Industries

By Product

  • Accessories And Consumables
  • Devices

By Setting

  • Academic And Research Institutes
  • Ambulatory Care Settings
  • Home Care Settings
  • Hospitals

ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030

Segment20232024202520262027202820292030CAGR (%)
AMBULATORY SURGICAL CENTERS (ASCS)1.711.751.821.91.982.062.142.234
HOMECARE SETTINGS1.61.651.731.811.891.982.072.164.6
HOSPITALS3.053.143.263.383.513.643.773.913.7
OTHER END-USE INDUSTRIES0.320.330.340.350.360.380.390.43.4
TOTAL6.686.887.157.447.748.058.378.74

Target Audience

  • Medical Device Manufacturers : Manufacturers seeking to expand elastomeric pump portfolios in Argentina need localized market data to assess opportunity size, competitive landscape, and regulatory requirements.
  • Healthcare Distributors & Suppliers : Regional distributors require Argentina-specific market insights to optimize inventory, identify growth segments, and develop effective sales strategies for infusion pump products.
  • Hospital & Clinic Administrators : Healthcare facility decision-makers need market data to justify technology investments, benchmark adoption rates, and plan procurement strategies for elastomeric infusion systems.
  • Investment & Private Equity Firms : Investors evaluating healthcare technology opportunities in Argentina require detailed market forecasts and growth metrics to assess portfolio companies and acquisition targets.
  • Market Research & Consulting Professionals : Analysts and consultants supporting clients in Argentina's healthcare sector need granular market data to develop strategies, validate assumptions, and support client recommendations.

Key Companies in the Argentina Elastomeric Infusion Pumps Market

CompanyHQOwnershipStrongest segments
BAXTERUnited StatesPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
NIPROJapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
AVNSUnited StatesPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
WOOYOUNG MEDICAL CO., LTD.South KoreaPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Electronic Infusion Pumps (adjacent),
SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.ChinaPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Accessories & Disposables for Elastomeric Pumps,
AMBU A/SDenmarkPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
DAIKEN MEDICAL CO., LTD.JapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate / PCA Elastomeric Pumps,Chemotherapy Applications,

BAXTER

Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates in the medical devices and pharmaceuticals sector.

NIPRO

Nipro is a Japanese public company founded in 1947 with 38,593 employees operating in the medical devices sector. The company serves global healthcare markets.

AVNS

AVNS is a privately held American company founded in 2014 with 2,287 employees. The company operates in the medical devices industry.

WOOYOUNG MEDICAL CO., LTD.

Wooyoung Medical Co., Ltd. is a privately held South Korean company founded in 1996. The company operates in the medical devices sector.

SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.

Shanghai Int Medical Instruments Co., Ltd. is a publicly traded Chinese medical device company founded in 2006 with 2,088 employees. The company serves the healthcare market.

AMBU A/S

Ambu A/S is a publicly traded Danish medical device company founded in 1937 with 5,200 employees. The company specializes in emergency and surgical equipment.

DAIKEN MEDICAL CO., LTD.

Daiken Medical Co., Ltd. is a publicly traded Japanese medical device company founded in 1968 with 185 employees. The company serves the healthcare industry.

Reasons to Buy this Report

  • Localized Market Intelligence : Gain Argentina-specific insights on market size, growth trajectories, and regional dynamics unavailable in global market reports, enabling targeted business strategy development.
  • Competitive Positioning Data : Understand Argentina's unique market landscape, healthcare provider preferences, and adoption patterns to identify competitive advantages and market entry opportunities.
  • Investment & Expansion Planning : Access detailed forecasts and market metrics for Argentina to support investment decisions, partnership development, and regional expansion strategies in South America.
  • Healthcare Provider Insights : Identify demand drivers specific to Argentine hospitals and clinics, including infrastructure needs, reimbursement trends, and technology adoption preferences.
  • Regulatory & Market Context : Understand Argentina's healthcare regulatory environment, distribution channels, and market barriers to inform product development and go-to-market strategies.

Frequently asked questions

What is the current market size of elastomeric infusion pumps in Argentina?

Argentina's elastomeric infusion pumps market is estimated at USD 7.2 million in 2025.

What is the projected market size for elastomeric infusion pumps in Argentina by 2030?

Argentina's elastomeric infusion pumps market is projected to reach USD 8.7 million by 2030.

What is the CAGR for the elastomeric infusion pumps market in Argentina?

Argentina's elastomeric infusion pumps market is expected to grow at a CAGR of 4.0% from 2025 to 2030.

What are the primary applications driving demand in Argentina's elastomeric infusion pumps market?

In Argentina, elastomeric infusion pumps are primarily used in oncology, pain management, and antibiotic therapy applications, with growing adoption in outpatient and home-based settings.

What factors are contributing to market growth in Argentina?

Argentina's market growth is driven by increasing chronic disease prevalence, healthcare infrastructure modernization, rising demand for portable drug delivery solutions, and expanding access to advanced medical devices.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the global elastomeric infusion pumps market. Exhaustive secondary research was conducted to gather information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of elastomeric infusion pumps through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the elastomeric infusion pumps market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

The market for companies offering elastomeric infusion pumps is determined by secondary data obtained from paid and unpaid sources, analyzing the product portfolios of major companies in the ecosystem, and evaluating companies based on their performance and quality. Various secondary sources, including Business Standard, Bloomberg, the World Bank, and Factiva, were consulted to identify and collect information for this study on the elastomeric infusion pumps market. During the secondary research process, various secondary sources were consulted to identify and collect information relevant to the study. Secondary sources included annual reports, press releases, investor presentations of door vendors, forums, certified publications, and white papers. The secondary research was utilized to gather critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from both market- and technology-oriented perspectives.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the elastomeric infusion pump market. After completing the market engineering process (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of elastomeric infusion pumps offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

The following is the breakdown of primary respondents:

Elastomeric Infusion Pumps Market

Notes: Other designations include sales, marketing, and product managers. Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were employed to estimate and validate the size of the global elastomeric infusion pumps market. These methods were also widely used to assess the size of various related market segments. The research methodology used to determine the market size included the following:

Elastomeric Infusion Pumps Market

Data Triangulation

After determining the overall market size using market size estimation processes, the market was segmented into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Elastomeric infusion pumps are portable, non-electronic medical devices designed for the controlled delivery of drugs, such as analgesics, antibiotics, and chemotherapeutic agents, over a specified period. These devices utilize the elastic properties of specific elastomers to deliver accurate, continuous, or intermittent medication infusions without requiring batteries or external power sources. Elastomeric infusion pumps are recognized for their simplicity, reliability, and ease of use, making them suitable for use in hospital, outpatient, and home care environments. They are produced and tested in accordance with international medical device standards, including ISO 13485 for quality management, ISO 11608 for infusion device efficacy, and ASTM standards for elastomeric materials. The devices are extensively utilized in oncology, pain management, anesthesia, and palliative care, enhancing patient compliance, mobility, and safety. Elastomeric infusion pumps are crucial to the advancement of the field of patient-centered drug delivery and healthcare innovation, particularly in home healthcare and ambulatory care.

Stakeholders

  • Elastomeric infusion pump manufacturers
  • Raw material suppliers
  • Converters & processors
  • Distributors and traders
  • Industry associations and regulatory bodies
  • End users

Report Objectives

  • To define, describe, and forecast the size of the global elastomeric infusion pumps market, based on type, end-use industry, and region in terms of value and volume
  • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
  • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
  • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • To analyze competitive developments such as acquisitions, expansions, partnerships, and agreements in the elastomeric infusion pumps market
  • To provide the impact of AI/Gen AI on the market

Get the Full Elastomeric Infusion Pumps Market Report

Full forecast, segment splits, and company analysis for all Elastomeric Infusion Pumps Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status